《異動》東方甄選(01797.HK)獲北水「加持」續漲近一成創兩年半高 個半月累飆3倍
在北水「加持」下,東方甄選(01797.HK)承過去八連升勢,今早(19日)低開0.9%後倒升,曾升12.5%高見48.8元創2023年2月以來約兩年半高,最新報47.6元,升9.73%,成交3,063.98萬股,涉資14.27億元。以6月30日收市價11.86元計,該股約一個半月累升逾3倍。
有機構指公司自營化轉型帶動GMV改善,符合新消費趨勢且有拓展空間,關注公司由主播驅動向產品驅動的轉型,留意本周五(22日)將公布中期業績。
東方甄選昨日(18日)單日錄北水淨流入約3億港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.